A5065444156- Diabetes Management and Research
- Mobile Health and mHealth Applications
- Diabetes Management and Education
- Diabetes Treatment and Management
- Artificial Intelligence in Healthcare
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Nutrition, Genetics, and Disease
- Digital Mental Health Interventions
- Cardiac and Coronary Surgery Techniques
- Health and Lifestyle Studies
- Diabetes and associated disorders
- Advanced Proteomics Techniques and Applications
- Consumer Attitudes and Food Labeling
- Cardiac Valve Diseases and Treatments
- Cardiovascular Health and Risk Factors
- Metabolomics and Mass Spectrometry Studies
- Pancreatic and Hepatic Oncology Research
- Gestational Diabetes Research and Management
- Pediatric Hepatobiliary Diseases and Treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiac, Anesthesia and Surgical Outcomes
- Diet and metabolism studies
- Pancreatic function and diabetes
- Chronic Disease Management Strategies
- Mental Health Research Topics
Brihanmumbai Municipal Corporation
2013-2023
Biotech Park
2022
KLE University
2021
LifeForce Homoeopathy (India)
2020-2021
Madras Diabetes Research Foundation
2013
Dr. Mohan's Diabetes Specialities Centre
2013
Bhatia Hospital
2013
Derriford Hospital
2009
MedPharm (United Kingdom)
2009
Measurement of the faecal markers calprotectin, lactoferrin and tumour M2-PK has been reported to be useful in diagnosis management a range gastrointestinal disorders both children adults. The aim this study was investigate requirement for age-related reference ranges.Faecal samples were obtained from 132 healthy subjects analysis performed using commercially available enzyme-linked immunosorbent assay.In median concentrations as follows: calprotectin - 2-9 y, 34 microg/g, 10-59 22 microg/g...
Background Digital therapeutics are evidence-based therapeutic interventions driven by high-quality software programs for the treatment, prevention, or management of a medical disorder disease. Many studies in western population have shown effectiveness mobile app–based digital improving glycemic control patients with type 2 diabetes (T2D). However, few assessed similar outcomes South Asian population. Objective This study aims to investigate real-world Wellthy CARE among Indian origin....
Digital therapeutic platforms facilitate health care through patient-centered strategies based on multidisciplinary teams and shared decision-making. Such can be used for developing a dynamic model of diabetes delivery, which help in improving glycemic control by promoting long-term behavior changes people with diabetes.This study aims to evaluate the real-world effectiveness Fitterfly Diabetes CGM digital therapeutics program type 2 mellitus (T2DM) after completion 90 days program.We...
India has over 62 million people with diabetes. Unfortunately, there are no trained diabetes educators in although many self-taught through experience. The National Diabetes Educator Program (NDEP) was initiated the primary aim to educate and train India. first cycle of NDEP conducted during period June 2011 March 2012 96 training centers 1032 mainly drawn from various clinics across country. Structured modules were taught by diabetologists/endocrinologists or experienced educators. A...
Background: Insurers in South Asia are challenged by lack of a culturally relevant and clinically effective lifestyle intervention that can be delivered at scale. This study reports results from participants real-world pilot using Wellthy Diabetes™ (WD), digital therapeutic for people living with type 2 diabetes, collaboration an insurance provider the aim to validate WD as diabetes management risk reduction tool. was developed scientific Research Society Study Diabetes India (RSSDI)....
Rice, or Oryza sativa/ glaberrima is the largest sources of carbohydrates, and calories, for mankind. It staple food across many countries America, Africa Asia. Hence, we need gluco-friendly ways incorporating rice-based menus into cuisine persons living with diabetes. This multinational article discusses this challenge, highlights importance informed shared decision making
Objective: People with type 2 diabetes mellitus are prescribed to complete a minimum of 30 mins activity every day. We evaluate the effectiveness Wellthy Diabetes (WD) digital therapeutic app in changing health behavior achieve these goals through routine activity, by coaching and nudging them help an artificial intelligence (AI) powered chatbot. Methods: De-identified data from 527 users [Mean = 38 years (95% CI: 36.8- 39.3); 69.7% male] who had used for at least 21 days tracking 15 was...
Background: High out of pocket expenses have led to poor diabetes self-management and glycemic control in India. This study evaluates the impact an iPDM (integrated personalized management) on blood glucose (BG) control. Methods: Study participants (n=286) used consisting Accu-Chek® Active BG meter Wellthy Care™ digital therapeutic platform (WDTx), which allowed them log values while receiving artificial intelligence-powered real-time feedback education. The at baseline (M0), month 2 (M2), 4...
Background: Diabetes self-reported clinical and lifestyle journey by the patient is very poor in India, unless significant additional time spent HCPs during appointments. We explored use of an iPDM (integrated personalized self-management) to amplify data, without adding any burden HCP. Method: Wellthy Care™ (WC) a digital therapeutic that delivers artificial intelligence (AI) augmented disease management program for people with diabetes. In this case, WC was given as companion Accu-Chek®...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Background: Lack of data on patient lifestyle between consultation visits is a major limitation in practice data-driven clinical decision making type 2 diabetes (T2DM). We showcase Wellthy Diabetes (WD), digital therapeutic, as an effective tool for the amplification patient's and journey to aid doctors decision-making. Methods: (WD) smartphone app therapeutic that delivers artificial intelligence (AI) augmented modification program people with T2DM, developed scientific collaboration...
Background: The glycaemic control among people with diabetes in India is very poor. This study evaluated the effectiveness an iPDM (integrated personalised self-management) changing health behavior to improve blood glucose levels. Methods: We used data from 883 participants (Average = 45.41 years; 72.71% male) who were using Accu-Chek® Active conjunction Wellthy Care™ digital therapeutic (WC DTx). had log sugar values into app manually. WC DTx, developed lines AADE7 and RSSDI guidelines,...
<sec> <title>BACKGROUND</title> Digital therapeutics are evidence-based therapeutic interventions driven by high-quality software programs for the treatment, prevention, or management of a medical disorder disease. Many studies in western population have shown effectiveness mobile app–based digital improving glycemic control patients with type 2 diabetes (T2D). However, few assessed similar outcomes South Asian population. </sec> <title>OBJECTIVE</title> This study aims to investigate...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
<sec> <title>BACKGROUND</title> Digital therapeutic platforms facilitate health care through patient-centered strategies based on multidisciplinary teams and shared decision-making. Such can be used for developing a dynamic model of diabetes delivery, which help in improving glycemic control by promoting long-term behavior changes people with diabetes. </sec> <title>OBJECTIVE</title> This study aims to evaluate the real-world effectiveness Fitterfly Diabetes CGM digital therapeutics program...
Background: Losing about 7% of body weight is known to reduce insulin resistance, blood pressure and the risk for diabetes. Large waistlines have been a marker metabolic syndrome. This study explores effectiveness Fitterfly Weight loss digital therapeutics (DTx) program among individuals in overweight obese categories. Method: De-identified data 135 participants (Mean age: 39.35 ± 11.83 years, gender: 38.51% (52/135) females) enrolled was analyzed. BMI range 25.0- 29.9 kg/m 2 ³ 30 used as...
Background: Long-term hyperglycemia is a potential risk factor for both macro and microvascular complications in Type 2 diabetes. Digital therapeutics platform can be highly accessible cost-effective way helping these patients with dietary, behavior change fitness advice aimed towards better glycemic control. Aims Objectives: To evaluate the effectiveness of Diabefly ® digital program using multidisciplinary approach participants type diabetes mellitus having HbA1c ≥9%. Results:...